Cheng Andrew sold AKRO
September 10, 2025 · Form 4 insider transaction
Cheng Andrew sold 158 shares of Akero Therapeutics, Inc. at $44.62 per share, a transaction worth $7.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
158
Price
$44.62
Total value
$7.0K
InsiderCheng Andrew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 10, 2025
Filing dateSeptember 12, 2025
Shares owned after475,698
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated August 16, 2024, previously adopted by the Reporting Person.